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The MAGUK Family Protein CARD11
Is Essential for Lymphocyte Activation
brane-associated guanylate kinase) family proteins such
as CASK, DLG, or PDS-95 have been shown to assemble
receptors, cytoskeletal components, and signaling mol-
Hiromitsu Hara,1,2 Teiji Wada,1,2 Chris Bakal,2
Ivona Kozieradzki,1,2 Shinobu Suzuki,2
Nobutaka Suzuki,2 Mai Nghiem,1,2
ecules at sites of cell-cell contact, including synapses,Emily K. Griffiths,1,2 Connie Krawczyk,1,2
cellular junctions, and polarized membrane domains (re-Birgit Bauer,3 Fulvio D’Acquisto,4 Sankar Ghosh,4
viewed in Fanning and Anderson, 1999; Caruana, 2002).Wen-Chen Yeh,2 Gottfried Baier,3
In analogy to neurons, antigen receptor stimulation in TRobert Rottapel,2 and Josef M. Penninger1,2,*
and B cells results in the assembly of antigen receptors,1Institute of Molecular Biotechnology
signaling molecules, and rafts to form supramolecularof the Austrian Academy of Sciences
activation clusters, the so-called immune synapseDr. Bohr Gasse 7
(Monks et al., 1997, 1998; Grakoui et al., 1999; PenningerA-1030 Vienna
and Crabtree, 1999; Dustin and Cooper, 2000).Austria
MAGUK family proteins function as molecular adapt-2 Ontario Cancer Institute
ers and contain an SH3 domain, one or multiple PDZUniversity Health Network and
domains, and a prototypical GuK domain. All MAGUKDepartments of Medical Biophysics and Immunology
family proteins are associated with the plasma mem-University of Toronto
brane where they can function as molecular scaffolds610 University Avenue
that tether membrane receptors to the intracellular sig-Toronto, Ontario M5G 2C1
naling machinery (Fanning and Anderson 1999; Caruana,Canada
2002). Genetic studies in flies have shown that MAGUK3 Institute for Medical Biology and Human Genetics
family proteins control the polarity of membrane do-University of Innsbruck
mains at epithelial cell junctions and play critical rolesSchoepfstrasse 41
in synaptic development (Tejedor et al., 1997; Hong etA-6020 Innsbruck
al., 2001). In Caenorhabditis elegans, the MAGUK familyAustria
protein Lin-2 regulates basolateral membrane localiza-4 Section of Immunobiology and
tion of the C. elegans EGF receptor LET-23 requiredDepartment of Molecular Biophysics and Biochemistry
for vulval induction (Kaech et al., 1998). In mammals,Howard Hughes Medical Institute
mutations of the MAGUK family proteins PSD-95 causesYale University School of Medicine
defects in synaptic plasticity and spatial learning (Mi-New Haven, Connecticut 06520
gaud et al., 1998) whereas loss of hDlg/SAP97 results
in profound craniofacial defects and perinatal lethality
(Caruana and Bernstein, 2001).Summary
Since immune and neuronal synapses share structural
similarities (Donnadieu et al., 2001; Dustin and Colman,Members of the MAGUK family proteins cluster recep-
2002), we reasoned that MAGUK family proteins aretors and intracellular signaling molecules at the neu-
candidate molecules for the assembly and/or organiza-ronal synapse. We report that genetic inactivation of
tion of supramolecular signaling complexes in lympho-the MAGUK family protein CARD11/Carma1/Bimp3 re-
cytes. In cell line studies, the caspase recruitmentsults in a complete block in T and B cell immunity.
domain (CARD)-containing MAGUK family proteinsCARD11 is essential for antigen receptor- and PKC-
CARD10 (Carma3, Bimp1), CARD11 (Carma1, Bimp3),mediated proliferation and cytokine production in T
and CARD14 (Carma2, Bimp2) associate with Bcl-10 via
and B cells due to a selective defect in JNK and NFB
CARD-CARD interactions, thereby activating the NFB
activation. Moreover, B cell proliferation and JNK acti- signaling pathway (Bertin et al., 2001; Gaide et al., 2001,
vation were impaired upon stimulation of TLR4 with 2002; McAllister-Lucas et al., 2001; Wang et al., 2001,
lipopolysaccharide, indicating that CARD11 is involved 2002; Pomerantz et al., 2002). However, in various cell
in both the innate and adaptive immune systems. Our lines different results were reported on the role of CARD-
results show that the same family of molecules are MAGUK family proteins in IL-2 production or JNK activa-
critical regulators of neuronal synapses and immune tion (Gaide et al., 2002; Wang et al., 2002). Another
receptor signaling. MAGUK family protein, the human lymphocyte homolog
of the Drosophila discs large tumor suppressor protein
Introduction (hDlg), has also been implicated in T cell activation and
organization of supramolecular activation clusters (Ha-
The nervous system and immune system utilize special- nada et al., 2000). Multiple other CARD-containing mole-
ized cell surface contacts to transduce signals between cules such as Cardinal (Bouchier-Hayes et al., 2001),
their constituent cell populations (reviewed in Dustin and CARD9 (Bertin et al., 2000), or CLAN (Damiano et al.,
Colman, 2002). These two synaptic junctions in neurons 2001) can associate with Bcl-10 and modulate Bcl-10-
and lymphocytes appear to share common structural dependent NFB activation. Moreover, CARD-con-
features. In neurons and epithelial cells, MAGUK (mem- taining molecules are not the only potential scaffolding
proteins involved in NFB activation. For instance,
MALT1, a protein containing caspase-like, Ig-like, and*Correspondence: josef.penninger@oeaw.ac.at
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Figure 1. Gene Targeting of card11
(A) Genomic card11 sequences and con-
struction of the neomycin resistance (Neo)
insertion vector. card11 exons are shown as
boxes. The card11 flanking probe used for
Southern blotting, expected fragment sizes
after digests of wild-type (3.6 kb) and mutant
(6.6 kb) genomic DNA are indicated. Exon 4
contains the start codon and encodes for the
CARD region.
(B) mRNA expression pattern of mouse
CARD11 detected by Northern blotting.
(C) Genomic DNA was isolated from
card11/, card11/, and card11/mice, di-
gested with Sac1, and analyzed by Southern
blotting using the 5 flanking probe shown
in (A).
(D) Western blot analysis of CARD11 protein
expression in card11/ and card11/ splen-
ocytes. Total cell lysates (10 g) were probed
with an anti-CARD11 Ab reactive against the
C terminus of mouse CARD11. -actin is
shown as a control.
death domains, can associate with Bcl-10 and synergis- Two independent card11/ ES cell lines were used to
establish two lines of mutant mice that showed the sametically activate NFB when overexpressed in 293T cells
(Lucas et al., 2001). Thus, whether MAGUK family pro- phenotype. card11/ mice were born at the expected
Mendelian frequency, were fertile, and appeared to beteins are indeed essential for lymphocyte activation in
vivo and the assembly of antigen receptor-triggered su- healthy.
pramolecular signaling complexes is as yet unknown.
We show that loss of CARD11 in mutant mice results CARD11 Controls Natural Killer Cell
in a complete block in T and B cell immunity. CARD11 and B Cell Development
is essential for antigen receptor- and PKC-mediated Since CARD11 protein is expressed in thymocytes,
proliferation and cytokine production in T and B cells. splenocytes, and lymph nodes, as well as purified
Loss of CARD11 results in a selective defect in JNK and T cells, B cells, and macrophages, but not total bone
NFB activation. Moreover, B cell proliferation and JNK marrow (data not shown), we first determined whether
activation were impaired upon stimulation of Toll-like deletion of card11 affected lymphopoiesis. card11/
receptor 4 (TLR4) with lipopolysaccharide (LPS), indicat- mice displayed normal numbers and differentiation of
ing that CARD11 is a molecule involved in both the innate B cells in the bone marrow (Figure 2A). However, the
and adaptive immune systems. number of IgDhighIgMlow splenocytes was reduced in
card11/ mice suggesting that CARD11 is required for
the terminal differentiation of mature B cells (Figure 2B).Results
Intriguingly, peritoneal CD5 B1 B cells were completely
absent in card11/ mice (Figure 2C). Moreover, inacti-Generation of card11 Mutant Mice
vation of card11 resulted in a marked decrease in theTo study the in vivo function of the MAGUK family protein
numbers of CD3IL-2R (Figure 2D) and CD3DX5CARD11, we disrupted the murine card11 gene in em-
(data not shown) natural killer cells in the spleen. Defec-bryonic stem (ES) cells using a targeting vector by which
tive NK cell differentiation correlated with impaired pro-nucleotides encoding amino acids 1 to 107 (exon 4 and
duction of IFN in IL-12- or IL-18-activated NK spleno-parts of exon 5) are removed (Figure 1A). Similar to
cytes (data not shown). Thus, CARD11 is required forhuman CARD11 (Bertin et al., 2001), murine CARD11
efficient development of NK cells, CD5 peritoneal BmRNA is highly expressed in the spleen, heart, and lung
cells, and mature IgDhighIgMlow splenic B cells in vivo.(Figure 1B). ES cell lines heterozygous for the mutation
These data show that MAGUK family proteins have in-at the card11 locus were used to generate chimeric
deed essential and nonredundant functions in a mam-mice, which were backcrossed to C57BL6 to obtain het-
malian species.erozygous card11/ mice. The intercross of card11/
mice produced homozygous card11/ mice, as con-
firmed by Southern blot analysis (Figure 1C). The null Normal Development and Selection of T Cells
Murine CARD11 has been recently cloned form a thymo-mutation of card11 was verified by the absence of
CARD11 protein in Western blot analysis (Figure 1D). cyte library (Pomerantz et al., 2002), and we detected
CARD11 Controls T and B Cell Functions
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Figure 2. Lymphocyte Populations in
card11/ Mice
Flow cytometric analysis of B cell develop-
ment in the bone marrow cells (A), splenic B
cells (B), peritoneal CD5 B cells (C), CD3IL-
2R NK cells (D), thymocytes (E), lymph
node T cells (F), positive selection of the HY
TCR in the thymus of female mice (G), and
negative selection of the HY TCR in the thy-
mus of male mice (H) from card11/ and
card11/ mice. Cells from 6-week-old mice
were stained with the indicated Abs. Percent-
ages of positive cells within each quadrant
are shown. Results are representative of five
different experiments.
strong CARD11 protein expression in thymocytes (data tions of lymph node and splenic T cells in female and
male HY TCR transgenic mice and surface expressionnot shown). Moreover, it has been shown that Bcl-10
has a role in thymocyte differentiation (Ruland et al., levels of the HY TCR were also comparable between
card11/ and card11/ mice in positive and negative2001). We therefore analyzed development and selec-
tion of T cells in the thymus. In contrast to B cells and selecting backgrounds (data not shown). These results
show that positive and negative T cell selection progressNK cells, numbers, subpopulations, and development
of thymocytes were unaffected by the card11 mutation normally in the absence of CARD11.
(Figure 2E). Moreover, the relative and total numbers of
peripheral CD4 and CD8 T cells in the lymph nodes CARD11 Is Essential for the Activation
of Mature T Cellsand spleen were comparable between card11/ and
card11/ mice (Figure 2F). Surface expression levels The functional role of CARD11 in antigen receptor-medi-
ated T cell activation has been controversial. For in-of TCR, CD3, CD4, CD8, CD69, CD25, CD5, IgM, IgD,
CD23, B220, and TCR	 on resting T cells and B cells stance, in previous studies using human T cell leukemia
lines, inhibition of CARD11 had either severe (Wang etwere also comparable between card11/and card11/
mice (data not shown). Thus, loss of CARD11 has no al., 2002) or only minimal effects (Gaide et al., 2002) on
IL-2 production in Jurkat cells stimulated with anti-CD3apparent affect on thymocyte differentiation or the ho-
meostasis of mature T cell populations. and anti-CD28. Thus, we wanted to determine whether
CARD11 indeed influences responses of primary T cellsTo test whether CARD11 has a role in antigen recep-
tor-driven positive and/or negative selection of thymo- in response to antigen receptor stimulation.
In vitro stimulation with anti-CD3
 mAb alone or anti-cytes, we crossed the MHC class I-restricted HY TCR
transgene on a card11 mutant background. In this sys- CD3
 plus anti-CD28 mAbs revealed a dramatic de-
crease in the proliferation (Figure 3A) and IL-2 produc-tem, the HY TCR is deleted in male mice via clonal
deletion and positively selected in female mice (Kisielow tion (Figure 3B) of peripheral card11/ T cells. These
defects could not be overcome at very high doses ofet al., 1998). Loss of CARD11 had no apparent affect
on positive and negative selection of thymocytes ex- the activating stimuli. Moreover, purified T cells from
card11/ mice did not respond to PMA and calciumpressing the MHC class I-restricted HY TCR transgene
(Figures 2G and 2H). It should be noted that the popula- ionophore (Figure 3C) indicating that CARD11 regulates
Immunity
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Figure 3. CARD11 Is Essential for T Cell Activation
(A and B) Proliferation (A) and IL-2 production (B) of purified card11/ and card11/ lymph node T cells stimulated with different concentrations
of soluble anti-CD3
 with or without soluble anti-CD28 (1 g/ml). Proliferation was determined 48 hr later by [3H]thymidine incorporation.
Levels of IL-2 were determined by ELISA. Values are mean SD for triplicate cultures.
(C) Proliferation and IL-2 production of purified card11/ and card11/ lymph node T cells stimulated with PMA (20 ng/ml) plus calcium
ionophore (100 ng/ml). Proliferation and IL-2 production were determined as in (A).
(D) Thymocyte proliferation. card11/ and card11/ thymocytes were stimulated with plate-bound anti-CD3 (0.1, 1, 10 g/ml) plus anti-CD28
(2 g/ml). Proliferation was determined 24 hr later by [3H]thymidine incorporation.
(E) Cell cycle profiles of card11/ and card11/ T cells following in vitro stimulation with anti-CD3
 (1 g/ml) plus anti-CD28 (1 g/ml). Cells
were labeled with BrdU and analyzed 24 hr after stimulation using FACS. Percentages of cells in the S phase are indicated.
(F) Flow cytometric analysis of activation markers. Purified lymph node card11/ and card11/ T cells were left untreated (control) or
stimulated with anti-CD3
 (1 g/ml) plus anti-CD28 (1 g/ml) for 24 hr and stained with antibodies against CD25, CD69, and CD44.
T cell activation downstream of PKCs. Interestingly, pro- (Figure 3D). In line with the defective proliferation, BrdU
labeling showed that card11/ T cells cannot enter theliferation of mature card11/ thymocytes in response to
CD3
 and CD28 stimulation was completely abrogated cell cycle following CD3
 stimulation (data not shown)
CARD11 Controls T and B Cell Functions
767
or CD3
 plus CD28 costimulation (Figure 3E). In addition severely impaired immunity to the T cell-dependent anti-
gen NP-OVA in vivo (Figure 5A). Thus, loss of CARD11to defective IL-2 production and cell cycle progression,
upregulation of the activation markers CD25 (IL-2 recep- has no apparent effect on T cell development in the
thymus, but CARD11 is an essential positive regulatortor  chain), CD69, and CD44 was also defective in
card11/ T cells (Figure 3F). Our genetic data in primary required for the activation and in vivo function of mature
T cells.T cells unequivocally establish CARD11 as an essential
adaptor molecule required for multiple effector func- In B cells, the defective in vitro B cell proliferation in
card11/ mice was paralleled in vivo by reduced basaltions downstream of the T cell antigen receptor and the
costimulatory CD28 receptor. levels of IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA immu-
noglobulins (Figure 5B). It should be noted that the se-
rum IgE levels in our card11/ mice were below theImpaired B Cell Activation
detection limit. To test whether these defects were in-The role of MAGUK family proteins in B cell function
deed intrinsic to B cells and not secondary to the im-and B cell antigen receptor (BCR) signaling is completely
paired T cell functions, card11/ mice were immunizedunknown. B cell development in the bone marrow ap-
with the T cell-independent (TI) polyvalent antigen TNP-pears to be normal in card11/ mice (Figure 2A). How-
Ficoll. Loss of CARD11 in mice resulted in a completeever, loss of CARD11 resulted in the complete absence
block of TNP-specific IgM and IgG3 production, indicat-of CD5 peritoneal B cells and reduced numbers of
ing that CARD11 expression is essential for T cell-inde-mature IgDhighIgMlow splenic B cells (Figures 2B and 2C),
pendent immune responses by B lymphocytes (Figuresuggesting that CARD11 has a role in B cell activation
5C). These results show that CARD11 is a molecularvia the B cell antigen receptor. We therefore analyzed
scaffold that is essential for the activation of mature Twhether loss of CARD11 has a role in B cell activation.
and B cells in vivo.Proliferation of card11/ splenic B cells was markedly
impaired in response to anti-IgM, but not IL-4, stimula-
tion (Figure 4A). Thus, CARD11 is also an essential scaf- CARD11 Couples Antigen Receptors and TLR4
fold involved in BCR-mediated B lymphocyte activation. to JNK and IB Degradation
Previously, it has been shown in transfection experi- It has been recently shown that overexpression or inhibi-
ments that CARD11 overexpression has no apparent tion of CARD11 in T cell tumor lines can affect NFB
effect on Toll-like receptor-mediated activation of Jurkat activation (Bertin et al., 2001; Gaide et al., 2001, 2002;
T cells (Pomerantz et al., 2002). Intriguingly, inactivation McAllister-Lucas et al., 2001; Wang et al., 2001, 2002;
of CARD11 markedly affected the proliferation of pri- Pomerantz et al., 2002). However, inhibition of CARD11
mary splenic B cells in response to different concentra- using dominant-negative CARD11 or RNAi only partially
tions of LPS (Figure 4B) which activates Toll-like recep- abolished NFB activation (Gaide et al., 2002; Pome-
tor 4 (reviewed in Beutler, 2000). Mechanistically, the rantz et al., 2002). Moreover, it has been reported that
impaired proliferation of card11/ splenic B cells in inhibition of CARD11 in Jurkat cells blocks TCR/CD28-
response to BCR stimulation was accompanied by de- induced JNK activation (Gaide et al., 2002) whereas the
fective cell cycle progression (Figure 4C). In addition, JNK activation induced by CD3-CD28 costimulation was
we observed markedly accelerated apoptosis in unstim- normal with even faster kinetics in JPM50.6 Jurkat cells
ulated and BCR-stimulated card11/ splenic B cells that do not express CARD11 (Wang et al., 2002). In
(Figure 4D). In contrast, LPS-stimulated card11/ B addition, CARD11 has been reported to directly associ-
cells displayed a block in cell cycle progression (Figure ate with the antigen receptor complex (Gaide et al.,
4C) but exhibited cell death that was comparable to 2002). Thus, the exact role and hierarchy of CARD11 in
CARD11-expressing control cells (Figure 4E). Of note, antigen receptor signaling has been controversial.
in card11/ thymocytes and mature T cells we observed To identify the molecular mechanism(s) that account
only defective cell cycle progression (Figure 3C) but not for the functional defects in card11/ T and B cells, we
enhanced cell death (data not shown). Thus, the cell analyzed signaling pathways downstream of TCR and
cycle block in card11/ B cells and T cells appears to BCR stimulation. card11/ and card11/ T and B cells
be the principal mechanism that accounts for defective exhibited comparable total tyrosine phosphorylation
proliferation. Importantly, our data establish a critical and calcium fluxes following anti-CD3
or anti-CD3
plus
role for the MAGUK family protein CARD11 in antigen anti-CD28 and anti-IgM stimulation, indicating that prox-
receptor-mediated cell cycle progression in B lympho- imal TCR and BCR signaling is not affected (Figures 6A,
cytes. Moreover, these results show that CARD11 is 6B, 7A, and 7B, and data not shown). Stimulation of
a molecular adaptor involved in both the innate and purified card11/ and card11/ lymph node T cells
adaptive immune systems. with anti-CD3
 or anti-CD3
 plus anti-CD28 and stimula-
tion of splenic B cells with anti-IgM also revealed no
apparent differences in the phosphorylation of Erk1/CARD11 Is Essential for In Vivo Immunity
To investigate whether the requirement for CARD11 in Erk2, AKT/PKB, and p38-MAPK (Figures 6C and 7C). In
contrast, inactivation of CARD11 in T cells resulted inlymphocyte activation and proliferation in vitro trans-
lated into a defective immune response in vivo, we chal- markedly impaired activation of the JNK signaling path-
way in response to TCR and CD28 stimulation (Figureslenged card11/ and card11/ mice with the T cell-
dependent antigen NP-OVA. Whereas card11/ lit- 6C). Similarly, JNK activation was completely abolished
in anti-IgM-stimulated splenic B cells (Figure 7C). More-termates produced high titers of NP-specific IgM, IgG1,
and IgG2a antibodies, this response was completely over, we observed impaired JNK activation downstream
of TLR4 activation with lipopolysaccharide (Figure 7D).absent in card11/ mice, and these mice displayed
Immunity
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Figure 4. Impaired B Cell Activation
(A and B) Proliferation of purified splenic B cells stimulated with anti-IgM to activate the BCR and IL-4 (A) or different concentrations of LPS
(B). Proliferation was determined 48 hr later by [3H]thymidine incorporation. Values are mean SD of triplicate cultures representative of three
experiments.
(C) Cell cycle profiles of card11/ and card11/ B cells left untreated (control) or following in vitro stimulation with anti-IgM F(ab)2 (5 g/
ml) and LPS (2 g/ml). Cells were labeled with BrdU and analyzed 24 hr after stimulation by FACS. Percentages of cells in the S phase are
indicated.
(D and E) Apoptosis of untreated and anti-IgM F(ab)2 (D) and LPS-stimulated (E) card11/ splenic B cells. Cell death was detected at 48 hr
using annexin V-propidium iodide staining. Values are mean numbers of viable B cells SD for triplicate cultures.
Thus, CARD11 is essential to couple antigen receptor of IB was markedly impaired in T cells (Figure 6D)
following antigen receptor and CD28 stimulation. Simi-and TLR4 stimulation to JNK activation.
In addition to defective JNK activation, degradation larly, degradation of IB was impaired in card11/
CARD11 Controls T and B Cell Functions
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Figure 5. CARD11 Is Essential for T and B
Cell Immunity In Vivo
(A) Impaired in vivo T cell immune responses
in card11/ mice to the T cell dependent
antigen NP-OVA. card11/ and card11/
mice were immunized with NP-OVA. Serum
anti-NP IgM, IgG1, and IgG2a titers were deter-
mined at the indicated times by ELISA. One
result representative of two independent ex-
periments is shown.
(B) Reduced basal serum immunoglobulin
levels in card11/ mice. Serum was col-
lected from 6-week-old card11/ and
card11/ mice, and Ig levels were deter-
mined using ELISA. Results from individual
mice are shown.
(C) Impaired in vivo B cell immunity in
card11/ mice to the T-independent antigen
TNP-Ficoll. card11/ and card11/ mice
were immunized with TNP-Ficoll (i.p.) and se-
rum anti-TNP IgM, and IgG3 titers were deter-
mined at the indicated times by ELISA.
thymocytes in response to anti-CD3
 and anti-CD28 Erk1/Erk2 activation in B cells. These data by two inde-
pendent groups and in two independent CARD11 mu-stimulation (Figure 6E), and loss of CARD11 in B cells
resulted in defective IB degradation following BCR tant mouse strains show that CARD11 is essential to
couple antigen receptor signaling to activation of thestimulation (Figure 7E). Importantly, the formation of
NFB/DNA complexes was severely impaired in purified JNK and NFB signaling pathways in thymocytes and
mature T and B cells.card11/ T cells following stimulation with anti-CD3
/
anti-CD28 (Figure 6F). Although card11/ lymphocytes
have defective JNK activation, the formation of AP-1/ CARD11 Functions Downstream of PKC
In T and B cells, PKC and PKC, respectively, haveDNA complexes appeared to be normal in gel-shift
assays (Figure 6F) presumably due to the normal p38- been shown to be essential to relay the initial antigen
receptor signal to NFB activation (Lin et al., 2000; SunMAPK activation. In contrast, TNF-mediated IB deg-
radation (Figure 6G), TNF-induced formation of NFB/ et al., 2000; Saijo et al., 2002). Moreover, PKC can
induce JNK activation in T cells (Villalba et al., 2000).DNA complexes, and JNK activation (data not shown)
appeared to be normal in card11/ T cells, indicating Since we observed defective T cell proliferation and
cytokine production following PMA/calcium ionophorethat loss of CARD11 expression affects NFB and JNK
activation in a receptor-specific manner. Similar to stimulation which directly activates PKC (Figures 3C),
we analyzed PKC activation and PKC-mediated down-T cells, NFB/DNA complex formation was defective in
purified card11/ B cells in response to antigen recep- stream signaling events. Using a PKC-specific phospho-
substrate Ab that detects target molecules phosphory-tor and PKC activation (Figure 7F). Jun et al. (2003 [this
issue of Immunity]) show that a point mutation of lated by PKC in T cells and PKC in B cells, we
observed normal PKC activation in T and B cells inCARD11 results in defective IB degradation and JNK
activation in response to BCR stimulation but normal response to anti-CD3
 plus anti-CD28 or anti-IgM (data
Immunity
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Figure 6. CARD11 Regulates JNK and NFB Activation in T Cells
(A) Total phosphotyrosine levels in purified card11/ and card11/ lymph node T cells stimulated with anti-CD3
 (10 g/ml) plus anti-CD28
(2 g/ml).
(B) Ca2 mobilization. Purified peripheral T cells from card11/ and card11/ mice were loaded with INDO-1 and stimulated with anti-CD3

followed by crosslinking (arrowhead). Ca2 flux was measured by flow cytometry. The x axis shows real-time Ca2 release followed for 220
s, and the y axis shows the intensity of the increase in intracellular Ca2 concentration.
(C) Activation of Erk1/Erk2, p38-MAPK, and JNK in purified card11/ and card11/ lymph node T cells activated with anti-CD3
 (10 g/ml)
plus anti-CD28 (10 g/ml). Active Erk1/Erk2 and p38-MAPK were detected by Western blotting using phosphospecific Abs. JNK activity was
determined in in vitro immunocomplex kinase assays using GST-cJun as a substrate. Levels of total ERK1/2, p38, and JNK are shown. Results
are representative of four independent experiments.
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not shown). Thus, loss of CARD11 does not affect PKC Senftleben et al., 2001). Our data show that CARD11 is
essential for in vivo immunity and proliferation of matureactivation downstream of antigen receptors.
We then stimulated T cells with the PKC-trigger PMA T and B cells and thymocytes. Results in mice transgenic
for nondegradable forms of IB suggested a role forand calcium ionophore to bypass proximal TCR and
BCR signaling events. Similar to antigen receptor activa- NFB in TCR-mediated thymocyte selection and in pre-
TCR survival signals (Hettmann and Leiden, 2000; Volltion, stimulation of lymph node T cells with PMA and
calcium ionophore resulted in normal Erk1/Erk1 phos- et al., 2000). This notion was reiterated by the phenotype
of PKC mutant mice that display normal NFB activa-phorylation but markedly impaired IB degradation
tion in thymocytes and normal thymocyte maturationand defective JNK activation (Figure 6D). IB degrada-
but impaired NFB activation and impaired activationtion was also impaired in PMA/ionophore card11/ thy-
in peripheral T cells (Sun et al., 2000). Since CARD11mocytes (Figure 6E). Furthermore, PMA and calcium
appears to function downstream of all PMA-responsiveionophore stimulation induces IkB degradation and JNK
PKC isoforms, we did not observe NFB activation inactivation in wild-type splenic B cells, a response that
card11/ thymocytes. Moreover, in contrast to IBwas abolished in card11/ B cells (Figure 7E). Thus,
transgenic mice, card11/ mice displayed normal posi-CARD11 acts downstream of all PKCs in T and B cells
tive and negative selection of thymocytes that expressand couples PKC stimulation to NFB and JNK acti-
the MHC class I-restricted H-Y TCR. Although CARD11vation.
is required for TCR/CD28-mediated NFB activation and
proliferation in thymocytes, it appears that other CARD
Discussion domain-containing molecules such as CARD10 or
CARD14 might be able to functionally compensate dur-
It has been recently shown that overexpression or inhibi- ing thymocyte selection. Moreover, since antigen recep-
tion of the MAGUK family member CARD11/Carma1/ tors in thymocytes and peripheral T cells display distinct
Bimp3 in T lymphoma cell lines can affect NFB activa- requirements for signaling molecules (Bachmaier et al.,
tion and that CARD11 and Bcl-10 synergize in NFB 2000), it is possible that thymocyte development and
activation in vitro (Bertin et al., 2001; McAllister-Lucas selection can occur in the absence of CARD11-regu-
et al., 2001; Pomerantz et al., 2002; Gaide et al., 2002; lated NFB activation. Importantly, our genetic data in
Wang et al., 2002). Inhibition of CARD11 using dominant- mature T cells unequivocally establish CARD11 as an
negative CARD11 or RNAi only partially abolished NFB essential molecule required for multiple effector func-
activation (Pomerantz et al., 2002; Gaide et al., 2002). tions downstream of the T cell antigen receptor and the
However, other CARD molecules such as CARD10, costimulatory CD28 receptor.
CARD14, CLAN, or CARD9 (Bertin et al., 2000, 2001; In previous studies using human T cell leukemia lines,
Bouchier-Hayes et al., 2001; Damiano et al., 2001; Wang the role of CARD11 in TCR signaling has been controver-
et al., 2001) can also associate with Bcl-10 and trigger sial. For instance, inhibition of CARD11 had either severe
NFB activation in vitro. Our results identify a critical (Wang et al., 2002) or only minimal effects (Gaide et al.,
role for CARD11 in NK and B cell development. In mature 2002) on IL-2 production in Jurkat cells stimulated with
T and B cells, CARD11 is essential for antigen receptor- anti-CD3 and anti-CD28. In addition, it has been re-
and TLR4-mediated cell cycle entry and cytokine pro- ported that inhibition of CARD11 in Jurkat cells blocks
duction in vitro and lymphocyte immunity to T and B cell- TCR/CD28-induced JNK activation (Gaide et al., 2002)
dependent antigens in vivo. Our results also revealed an whereas the JNK activation induced by CD3-CD28 co-
essential function for the CARD11 molecule in B lympho- stimulation was normal with even faster kinetics in
cyte biology. JPM50.6 Jurkat cells that do not express CARD11 (Wang
Mice that carry mutations in molecules that control the et al., 2002). It has also been shown that CARD11 can
NFB signaling pathway have revealed that the proper associate with the TCR complex suggesting that
regulation of NFB is critical for normal innate and adap- CARD11 might play a direct role in antigen receptor
tive immune responses (reviewed in Gerondakis et al., signaling and/or the recruitment of the antigen receptor
1999). For instance, in innate immunity, the NFB path- into lipid rafts (Gaide et al., 2002). Our genetic and func-
way is required for signaling via Toll-like receptors or tional results show that inactivation of CARD11 does
signaling via the proinflammatory cytokines such as not affect proximal antigen receptor signaling, calcium
TNF and IL-1 (Zhang and Ghosh, 2000). In adaptive signaling, and activation of PKCs, AKT, ERK, or p38-
immunity, T cells lacking c-Rel, RelA, or IKK develop MAPK. However, CARD11 is a critical regulator of JNK
but fail to proliferate normally in response to TCR/CD28 and NFB activation following antigen receptor and
TLR4 stimulation.costimulation (Kontgen et al., 1995; Doi et al., 1997;
(D) IB degradation, and JNK and Erk1/Erk2 phosphorylation in card11/ and card11/ lymph node T cells stimulated with anti-CD3
 (10
g/ml) plus anti-CD28 (10 g/ml) and PMA (50 ng/ml) plus calcium ionophore (50 ng/ml). Results are representative of three independent
experiments.
(E) Defective IB degradation in card11/ and card11/ thymocytes stimulated with anti-CD3
 (10 g/ml) plus anti-CD28 (2 g/ml) and
PMA (50 ng/ml) plus calcium ionophore (50 ng/ml). Results are representative of three independent experiments.
(F) EMSA. Nuclear extracts were obtained from purified card11/ and card11/ T cells left untreated (control) or treated with plate-bound
anti-CD3
 (10 g/ml) plus anti-CD28 (10 g/ml) or PMA (50 ng/ml) plus calcium ionophore (50 ng/ml) as described. Electromobility shift assays
were performed using consensus NFB and AP-1 oligonucleotides. Results are representative of four independent experiments.
(G) Normal IB degradation in purified card11/ and card11/ lymph node T cells stimulated with TNF (10 ng/ml).
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Figure 7. Impaired JNK and NFB Activation in card11/ B Cells
(A) Total phosphotyrosine signaling in purified card11/ and card11/ splenic B cells stimulated with anti-IgM F(ab)2 (10 g/ml). Results
are representative of three experiments.
(B) Ca2 mobilization. Purified splenic B cells from card11/ and card11/ mice were loaded with INDO1 and stimulated with anti-IgM F(ab)2
(10 g/ml). Ca2 flux was measured by FACS.
(C) Activation of JNK, Erk1/Erk2, and AKT/PKB in purified card11/ and card11/ splenic B cells activated with anti-IgM F(ab)2 (10 g/ml).
Active JNK, Erk1/Erk2, and AKT/PKB were detected by Western blotting using phosphospecific Abs. Total JNK, Erk1/Erk2, and AKT/PKB
levels are shown. Results are representative of four independent experiments.
(D) JNK activation in card11/ and card11/ splenic B cells stimulated with the TLR4 agonist LPS (2 g/ml).
(E) IB degradation and JNK activation in card11/ and card11/ splenic B cells stimulated with anti-IgM F(ab)2 (10 g/ml) and PMA (50
ng/ml) plus calcium ionophore (50 ng/ml). -actin is shown as a protein loading control. Results are representative of four independent
experiments.
(F) EMSA. Nuclear extracts were obtained from purified card11/ and card11/ splenic B cells left untreated (control) or treated with anti-
IgM F(ab)2 (10 g/ml) and PMA (50 ng/ml) plus calcium ionophore (50 ng/ml).
CARD11 Controls T and B Cell Functions
773
Previously, it has been shown in transfection experi- proteins have indeed essential and nonredundant func-
ments that CARD11 overexpression has no apparent tions in the immune system.
effect on Toll-like receptor-mediated activation of Jurkat
Experimental ProceduresT cells using dsRNA (Pomerantz et al., 2002). Thus, it
has been suggested that CARD11 selectively functions
Generation of card11 Mutant Micedownstream of the TCR. Intriguingly, inactivation of The murine card11 gene was cloned using ESTs with homology to
CARD11 markedly affected the proliferation and cell cy- human card11. For gene targeting, a genomic card11 fragment was
cle progression of primary splenic B cells in response isolated from a 129/J mouse library. The targeting construct was
electroporated into E14K ES cells, and transfectants resistant toto lipopolysaccharide which activates TLR4 (Beutler,
G418 were screened for homologous recombination by PCR and2000). Moreover, we observed impaired JNK activation
Southern blotting. Only littermate mice were analyzed in this study.downstream of TLR4 activation with LPS. Thus, CARD11
HY TCR Tg mice have been described previously (Kisielow et al.,is essential to couple TLR4 stimulation to B cell prolifera-
1998). All mice were maintained at the animal facilities of the Ontario
tion and JNK activation. Whether signaling of other TLRs Cancer Institute according to institutional guidelines. Northern blot
is affected by the loss of CARD11 needs to be deter- analysis was performed by probing a mouse multiple tissue Northern
mined. Similar to CARD11, it has been recently shown blot (Clontech) according to the manufacturer’s instructions with a
32P-labeled probe encompassing the C-terminal 590 nucleotides ofthat the CARD-containing serine/threonine kinase Rip2/
murine CARD11 cDNA. CARD11 protein expression was detectedRICK/CARDIAK transduces signals from both antigen
by Western blotting using a rabbit Ab directed against the C terminusreceptors and TLRs following lipopolysaccharide stimu-
(VEEQRKTIWVDEDQL) of mouse CARD11.
lation (Kobayashi et al., 2002). It has also been shown
that LPS-induced JNK activation is dependent on PKC Cytometry
expression, indicating that PKCs are critically involved Single-cell suspensions of thymi, lymph nodes, bone marrow, and
at an early stage of LPS-mediated signaling (Procyk et spleens from card11/ and card11/ mice were stained with FITC-,
PE-, or biotin-conjugated Abs (Bachmaier et al., 2000). Biotinylatedal., 2000). Of note, LPS-induced B cell activation ap-
Abs were visualized using streptavidin-RED670. For detection ofpeared to be normal in Bcl10 knockout mice (Ruland et
apoptosis, activated splenic B cells and lymph node T cells (1 al., 2001). It would be interesting to explore whether
106) were stained with annexin V/propidium iodide (PI) using the
Rip2 can associate with CARD11 via CARD-CARD inter- Apoptosis Detection Kit (R&D Systems). All samples were analyzed
actions downstream of TLRs. Importantly, our results by flow cytometry using a FACScan (Becton Dickinson).
show that CARD11 is a molecular adaptor involved in
both the innate and adaptive immune systems. Lymphocyte Activation
Lymph node T cells were purified using magnetic beads (Dynal) toThere are some notable differences between our
remove B220-, Mac-1-, and Gr-1-positive cells. Purified T cellsCARD11 null mutant mice and CARD11/Carma1 point
(95% CD3 by FACS) and thymocytes were placed into 96-wellmutant mice generated by Jun et al. (2003). These point
plates in RPMI media with 10% FCS. T cells were stimulated with
mutant mice still express CARD11/Carma1 protein. Both anti-CD3
 (145-2C11, Pharmingen), anti-CD28 (37.51, Pharmingen),
mouse lines display very similar B cell maturation and PMA (Sigma) plus Ca2 ionophore A23617 (Sigma), and rmIL-2
B cell activation defects whereas T cell activation in (R&D Systems) as indicated in the figures. Splenic B cells were
purified using magnetic beads (Dynal) to remove Mac-1-, Gr-1-, andresponse to anti-CD3 plus anti-CD28 and LPS stimula-
Thy1.2-positive cells. Purified B cells (95% B220 by FACS) weretion in B cells is different between our null mice and the
stimulated with various concentrations of anti-IgM F(ab)2 fragmentmice of Jun et al. Intriguingly, despite the functional
(Jackson ImmunoResearch), rmIL-4 (R&D Systems), and lipopoly-differences in T cells, the signaling defects appear to
saccharide (Sigma). Cells were stimulated in triplicate followed by
be similar in both mutant lines. Thus, signaling pathways an 8 hr pulse with 1 Ci per well [3H]thymidine (Amersham). Culture
other than NFB and JNK might be affected by the supernatants were assayed in triplicate for the production of IL-2 by
complete loss of CARD11 but not by a point mutation ELISA (R&D Systems). To examine activation marker upregulation,
purified T cells were harvested and cell surface expression levelsof the CARD11 coiled-coil domain. This point mutation
were evaluated by flow cytometry. Cell cycle analysis in T and Bof CARD11 might selectively interfere with defined sig-
cells was performed using a BrdU Flow Kit (Pharmingen). In brief,naling pathways whereas complete loss of CARD11 ap-
24 hr after stimulation cells were pulsed with BrdU (10 M) for 16pears to impede additional pathways downstream of
hr and analyzed by flow cytometry.
TCR and TLR4 stimulation. Importantly, the CARD11
point mutant mice suggest that the coiled-coil domain In Vivo Immunity
is absolutely critical for the development and activation Mice were immunized i.p. with either 100 g NP-OVA adsorbed to
alum (Sigma) or with 10 g TNP-Ficoll. NP-specific sera titers (1:100of B cells and CD28-dependent T cell activation. These
serum dilution) were determined by ELISA on NP-BSA-coated platestwo different mouse lines should also be useful for com-
(Nunc). TNP-specific titers were determined by ELISA on TNP-BSA-paring and defining specific signaling pathways that me-
coated plates. NP-OVA, NP-BSA, TNP-Ficoll, and TNP-BSA werediate TCR/CD3 versus CD28 costimulatory signals.
purchased from Biosearch Technologies. Basal levels of Ig isotypes
In conclusion, we have shown that CARD11 is a critical were analyzed by ELISA on serially diluted serum samples using
positive regulator of T and B cell activation and function. anti-mouse IgG1, IgG2a, IgG2b, IgG3, IgA, or IgM antibodies (South-
Moreover, CARD11 is required for efficient development ern Biotechnology Associates, Birmingham, AL) according to the
manufacturer’s directions.of NK cells and CD5 peritoneal B cells in vivo. In addi-
tion, proliferation of card11/B cells was impaired upon
Antigen Receptor and TLR4 Signaling Assaysstimulation of TLR4 with lipopolysaccharide, indicating
T cells and thymocytes were stimulated either with hamster anti-that CARD11 is involved in both the innate and adaptive
CD3
 (145-2C11, Pharmingen) plus hamster anti-CD28 (37.51, Phar-
immune systems. CARD11 is essential for antigen mingen) followed by crosslinking with anti-hamster IgG (Jackson
receptor-, TLR4-, and PKC-induced IKK activity, IB ImmunoResearch), or with PMA (Sigma) plus calcium ionophore
degradation, NFB activation, and JNK activation. A23187 (Sigma). B cells were stimulated with anti-mouse IgM F(ab)2
(Jackson ImmunoResearch) or different doses of lipopolysaccha-These data provide genetic evidence that MAGUK family
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ride. After incubation at 37C for various time periods, cells were Caruana, G. (2002). Genetic studies define MAGUK proteins as regu-
lators of epithelial cell polarity. Int. J. Dev. Biol. 46, 511–518.lysed in ice cold lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl,
1.0% Triton X-100, 20 mM EDTA, 1 mM Na3VO4, 1 mM NaF, and Caruana, G., and Bernstein, A. (2001). Craniofacial dysmorphogen-
protease inhibitors) and subjected to Western blotting using Abs esis including cleft palate in mice with an insertional mutation in the
against anti-phosphotyrosine (PY99, SantaCruz), phospho-ERK1/2, discs large gene. Mol. Cell. Biol. 21, 1475–1483.
ERK1/2, phospho-p38-MAPK, p38-MAPK, phospho-JNK, total JNK,
Damiano, J.S., Stehlik, C., Pio, F., Godzik, A., and Reed, J.C. (2001).
IB, phospho-S473-AKT, AKT (all from Cell Signaling), and actin
CLAN, a novel human CED-4-like gene. Genomics 75, 77–83.
(C-2, Santa Cruz). For calcium mobilization studies, freshly isolated
Doi, T.S., Takahashi, T., Taguchi, O., Azuma, T., and Obata, Y. (1997).peripheral T and B cells were loaded with 3 mM INDO-1 (Molecular
NF-B RelA-deficient lymphocytes: normal development of T cellsProbes) in IMDM for 1 hr at 37C. After loading, cells were incubated
and B cells, impaired production of IgA and IgG1 and reduced prolif-with anti-CD3
 for 20 min at 4C. Cells were washed, and anti-CD3

erative responses. J. Exp. Med. 185, 953–961.molecules were crosslinked at 37C with rabbit anti-hamster IgG
Donnadieu, E., Revy, P., and Trautmann, A. (2001). Imaging T-cell(Jackson Laboratories). B cells were stimulated by addition of anti-
antigen recognition and comparing immunological and neuronalIgM F(ab)2. Cytosolic Ca2 flux was recorded in real time on live-
synapses. Immunology 103, 417–425.gated cells using a FACS-Vantage.
Dustin, M.L., and Cooper, J.A. (2000). The immunological synapse
and the actin cytoskeleton: molecular hardware for T cell signaling.JNK Activity Assays
Nat. Immunol. 1, 23–28.To detect JNK activity, JNK proteins were immunoprecipitated at
4C using an anti-JNK polyclonal Ab (C-17, Santa Cruz). Kinase Dustin, M.L., and Colman, D.R. (2002). Neural and immunological
activity was determined using GST-c-Jun as a substrate in the pres- synaptic relations. Science 25, 785–789.
ence of 60 M [-32P]ATP. Fanning, A.S., and Anderson, J.M. (1999). Protein modules as orga-
nizers of membrane structure. Curr. Opin. Cell Biol. 11, 432–439.
Electromobility Shift Assays Gaide, O., Martinon, F., Micheau, O., Bonnet, D., Thome, M., and
Nuclear extracts were harvested from 2  107 cells according to Tschopp, J. (2001). Carma1, a CARD-containing binding partner of
previously described protocols (Su et al., 2002). In brief, protein Bcl10, induces Bcl10 phosphorylation and NF-kB activation. FEBS
extracts (4 g) were incubated in 20 l binding buffer with end- Lett. 11, 121–127.
labeled, double-stranded oligonucleotide probes (NFB, 5-ATCAG
Gaide, O., Favier, B., Legler, D.F., Bonnet, D., Brissoni, B., Valitutti,
GGACTTTCCGCTGGGGACTTTCCG-3; AP-1, 5-CGCTTGATGAC
S., Bron, C., Tschopp, J., and Thome, M. (2002). CARMA1 is a critical
TCAGCCGGAA-3), and fractionated on a 5% polyacrylamide gel.
lipid raft-associated regulator of TCR-induced NF-kB activation.
The NFB binding buffer was 5 mM HEPES (pH 7.8), 50 mM KCl,
Nat. Immunol. 3, 836–843.
0.5 mM dithiothreitol, 2 g poly (dI-dC), and 10% glycerol. The AP-1
Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T., and Gru-binding buffer was 10 mM Tris-HCl (pH 7.5), 100 mM KCl, 0.5 mM
mont, R. (1999). Genetic approaches in mice to understand Rel/NF-MgCl2, 0.1 mM EDTA, 0.5 mM dithiothreitol, 2 g poly (dI-dC), and
kappaB and IkappaB function: transgenics and knockouts. Onco-10% glycerol.
gene 18, 6888–6895.
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